KIF2A and diffuse large B-cell lymphoma: In total, 64.93% (87/134) of tissue samples from DLBCL patients and 40.35% (23/57) from those with reactive hyperplasia showed high expression of KIF2A (χ2 = 9.8879, P = 0.002).